Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 85-96 of 152
» View wsbt.com items only
    Sep 25, 2011 |Story| Reuters
  1. Cancer study boosts hopes for Roche's armed antibody

    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday.
    Reuters
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...

    Tags: Diseases and Illnesses, Hair Loss, Health Treatments, Biotechnology, Chemotherapy

  2. Sep 27, 2011 |Story| Chicago Tribune
  3. Drug companies pay $25 million to Illinois doctors

    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...

    Tags: Research, Chemical Industry, Merck & Company Incorporated, AstraZeneca Plc, Trips and Vacations

  4. Sep 20, 2011 |Story| Reuters
  5. Tailored breast cancer drugs in focus at cancer meet

    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
    Reuters
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...

    Tags: Diseases and Illnesses, Human Body, Litigation, Head, Health Treatments

  6. Nov 2, 2011 |Story| Reuters
  7. Study: At-home cervical cancer test could save thousands

    A do-it-yourself test for cervical cancer could help prevent thousands of cases of the disease in women who don't have easy or regular access to smear tests, scientists said Wednesday. The DIY test, which detects the human papillomavirus (HPV)...

    Tags: Diseases and Illnesses, University of Washington, Merck & Company Incorporated, Research, Vaccines

  8. Nov 24, 2011 |Story| Reuters
  9. UK switches to Merck's Gardasil for HPV vaccination

    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
    Reuters
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...

    Tags: Pharmaceuticals, Diseases and Illnesses, Merck & Company Incorporated, Chemical Industry, Vaccines

  10. Sep 19, 2011 | Los Angeles Times
  11. Malaria vaccine: The fiction and the reality

    Opinion L.A.
    Ann Patchett has earned all sorts of praise for her bestseller, "State of Wonder," but as engaging as the story is, the book's science concerning a malaria vaccine left something -- well, several things -- to be desired. The reality is that with all the...
  12. Oct 28, 2010 |Story| Chicago Tribune
  13. Doctor-drug company database adds to confusion for consumers

    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues. He found several doctors who had potentially compromising...

    Tags: Merck & Company Incorporated, Research, Chemical Industry, Colleges and Universities, AstraZeneca Plc

  14. Nov 6, 2009 |Story| Los Angeles Times
  15. High hopes for a malaria vaccine

    Each year, malaria kills more than 1 million people -- 90% of them in sub-Saharan Africa and 80% of them younger than 5 -- and makes 300 million people seriously ill. Major progress in controlling the disease has been made by the widespread adoption of...

    Tags: Pharmaceuticals, Diseases and Illnesses, Litigation, Vaccines, Children

  16. Nov 30, 2009 |Story| Los Angeles Times
  17. Gauging a gas tackler

    Whether you're still plowing through Thanksgiving leftovers or easing back to your normal fare, billions of bacteria in your digestive tract are eagerly awaiting their next meal. And if you feed them well enough, they'll thank you by producing gas.
    Whether you're still plowing through Thanksgiving leftovers or easing back to your normal fare, billions of bacteria in your digestive tract are eagerly awaiting their next meal. And if you feed them well enough, they'll thank you by producing gas....

    Tags: Colon, Flatulence, Entertainment, Colleges and Universities, Washington (U.S. state)

  18. Mar 30, 2011 |Story| Reuters
  19. Expectations affect benefits of pain drug

    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report.
    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report. Researchers from Britain and Germany used brain scans...

    Tags: University of Oxford, Abbott Laboratories, Health, MRI (imaging), Medical Research

  20. Jun 20, 2011 |Story| Reuters
  21. |Story
  22. Feb 7, 2011 |Story| Reuters
  23. Glaxo adds safety restrictions to Avandia label

    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
    Reuters
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...

    Tags: Pharmaceuticals, Diseases and Illnesses, Physical Conditions, Chemical Industry, IMS Health Incorporated

< Previous1 2 3 4 5 6 7  8  9 10 11-13Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
CEO of GlaxoSmithKline, Andrew Witty, poses for photogr...
(July 2, 2012)
CEO Andrew Witty